Evidence-based, peer-reviewed studies have shown that a single dose of HA after a procedure accelerates tissue healing, enhances bone formation, and reduces probing pocket depth in various dental ...

A newly presented study has uncovered troubling molecular changes in the cervix associated with a common parasitic infection, ...

Biocon’s share price rose 5.5% after USFDA approved JOBEVNE, a biosimilar cancer drug. This marks the company’s seventh USFDA ...

A roundup of 2025's most impactful nanomaterial innovations. From energy storage and flexible electronics to cancer treatment ...

Jobevne is a vascular endothelial growth factor (VEGF) impediment that sticks with VEGF and restrain the interaction with its ...

Anemia is a common condition in premature infants, particularly those at risk for retinopathy of prematurity (ROP).

The U.S. Food and Drug Administration has approved Jobevne (bevacizumab-nwgd), a biosimilar to Avastin (bevacizumab) for ...

Biocon Biologics, a subsidiary of Biocon Ltd, announced on Thursday that it has received approval from the United States Food ...

Biocon Biologics (BBL), a subsidiary of Biocon, today announced that the U.S. Food and Drug Administration (U.S. FDA) has approved Jobevne (bevacizumab-nwgd), a biosimilar Bevacizumab for intravenous ...

Biocon Biologics Limited (BBL) announced on Thursday that it had received approval from the United States Food and Drug ...

FDA approves Biocon Biologics' Jobevne, a biosimilar Bevacizumab for cancer treatment, expanding access to affordable ...